Why Beach, Bendigo and Adelaide Bank, Opthea, and Paradigm shares are sinking

These ASX shares are having a bad start to the week…

| More on:
Close up of a sad young woman reading about declining share price on her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.6% to 7,072.6 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are dropping:

Beach Energy Ltd (ASX: BPT)

The Beach share price is down 12% to $1.63. Investors have been selling this energy producer's shares after its FY 2022 profits fell well short of expectations. Beach reported an underlying net profit after tax of $504 million. While this was up 39% year over year, it was nowhere near the consensus estimate of ~$546 million.

Bendigo and Adelaide Bank Ltd (ASX: BEN)

The Bendigo and Adelaide Bank share price is down over 8% to $9.89. This follows the release of the regional bank's FY 2022 results. Although the bank delivered a full year profit that was largely in line with expectations, its net interest margin (NIM) commentary appears to have disappointed investors. Goldman Sachs notes that "today's (NIM) update is disappointing."

Opthea Ltd (ASX: OPT)

The Opthea share price is down 9% to $1.27. This morning this clinical stage biopharmaceutical company announced that it has received binding commitments for a US$90 million placement to institutional investors. These funds were raised at a 17% discount of $1.15 per new share. The proceeds will be used to support phase 3 clinical trials of OPT-302.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

The Paradigm share price has crashed 27% lower to $1.45. This was also driven by a capital raising. The biopharmaceutical company is raising $66 million at $1.30 per new share. This represents a huge discount of 34.5% to the company's last close price of $1.985. Some of the proceeds will be used for Paradigm's phase 3 clinical program and new drug application-related activities.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Bendigo and Adelaide Bank Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Firefly Metals, Pantoro Gold, Step One, and Vulcan Energy shares are sinking today

These shares are having a tough session on Thursday.

Read more »

A young man clasps his hand to his head with a pained expression on his face and a laptop computer in front of him.
Share Fallers

Why Block, Collins Foods, Perseus Mining, and Robex Resources shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward representing the ASX tech share sell-off today
Share Fallers

The 4 worst performing ASX 200 stocks to hold in November unmasked

Investors would have done well to avoid these four ASX 200 stocks in November.

Read more »

a person holds their head in their hands as they slump forward over a laptop computer which features a thick red downward arrow zigzagging downwards across the screen.
Share Fallers

Why did the DroneShield share price crash 48% in November?

Investors pummelled DroneShield shares in November. Let’s see why.

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why ASX, AUB, Dyno Nobel, and HMC shares are sinking today

These shares are starting the week in the red. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why these ASX 200 shares crashed 10%+ in November

Let's see why these shares were sold off last month.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Harvey Norman, Mirvac, Qube, and Suncorp shares are falling today

These shares are ending the week in the red. But why?

Read more »